J9295 Injection, necitumumab, 1 milligrams
Also known as: necitumumab, Portrazza
Injection of necitumumab, 1 milligram. An epidermal growth factor receptor monoclonal antibody for non-small cell lung cancer.
In Plain Language
lung cancer injection; targeted cancer treatment
Clinical Context
Used for squamous non-small cell lung cancer with cisplatin and gemcitabine. Provides survival benefit in first-line metastatic disease.
RVU Information
CPT J9295 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9295?
CPT J9295 (Injection, necitumumab, 1 milligrams) is a J Codes (Drugs) code. Injection of necitumumab, 1 milligram. An epidermal growth factor receptor monoclonal antibody for non-small cell lung cancer.
How is J9295 administered?
CPT J9295 is administered by a healthcare provider, typically via injection or infusion. Used for squamous non-small cell lung cancer with cisplatin and gemcitabine. Provides survival benefit in first-line metastatic disease. It is used by Oncology, Pulmonology, Surgery.
When is CPT J9295 used?
Used for squamous non-small cell lung cancer with cisplatin and gemcitabine. Provides survival benefit in first-line metastatic disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.